Background
As diagnosis and treatment of hepatitis C expand to achieve global hepatitis elimination goals, we have a unique opportunity to optimise hepatitis C treatment through maximising population-level outcome and prevention and responding to possible emergence of drug-resistant hepatitis C.
This webinar provided an overview of current knowledge on hepatitis C drug resistance in low- and middle-income countries and presented WHO’s plan to prevent, monitor and respond to possible hepatitis C drug resistance in an integrated Global Action Plan linking drug resistance for viral hepatitis, HIV and sexually transmitted infections.
Objectives
- to provide an overview of current knowledge, research gaps and public health implications related to hepatitis C drug resistance in low- and middle-income countries;
- to advocate and increase awareness as part of a comprehensive response to viral hepatitis drug resistance; and
- to provide an overview of the development and key aspects of an evolving integrated global action plan to prevent monitor and respond to drug resistance for HIV, viral hepatitis, and sexually transmitted infections.
Date:
Wednesday, 22 November 2023, 13:00-14:30 CET.
Language:
The webinar was held in English.